Skip to content

I-DECIDE After Bronchiolitis Hospitalization

Cluster Randomized Trial of a Moderate vs High Resource Implementation Strategy to Increase As-needed Post-hospitalization Follow-up for Children With Bronchiolitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07243652
Acronym
I-DECIDE
Enrollment
2700
Registered
2025-11-24
Start date
2025-11-01
Completion date
2029-12-01
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis Acute

Brief summary

Although automatic follow-up is a nearly universal practice, research has shown that these visits are often unnecessary after hospitalizations caused by bronchiolitis. Despite endorsement by national pediatric authorities, robust evidence, and family enthusiasm for as-needed (PRN) follow-up, it remains substantially underutilized for children hospitalized for bronchiolitis. The goal of I-DECIDE is to compare the effects of two multi-component implementation strategies, both of which aim to (a) increase PRN follow-up prescribing by hospitalists (physicians who care for hospitalized children) and (b) decrease unnecessary follow-up visit attendance by families.

Interventions

OTHERModerate-Resource Implementation Strategy

The moderate-resource implementation strategy includes educational outreach (including family-facing materials to support follow-up decision making), audit and feedback (review of clinician performance, captured in a structured report), and materials for clinical decision support.

OTHERHigh-Resource Implementation Strategy

The high-resource implementation strategy includes all of the moderate resource components, plus two forms of external facilitation: small-group facilitation and expert clinical decision support coach-led facilitation. In total, the high-resource implementation strategy includes educational outreach (including family-facing materials to support follow-up decision-making), audit and feedback (review of clinician performance, captured in a structured report), materials for clinical decision support, small-group facilitation and expert clinical decision support coach-led facilitation.

Sponsors

Seattle Children's Hospital
Lead SponsorOTHER
Patient-Centered Outcomes Research Institute
CollaboratorOTHER
Children's Hospital of Philadelphia
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
0 Months to 24 Months
Healthy volunteers
No

Inclusion criteria

* Primary diagnosis of bronchiolitis, discharged by a generalist inpatient service from a non-ICU, non-emergency department, non-step down unit

Exclusion criteria

* Children with a history of gestational age \<28 weeks, chronic lung disease, complex or hemodynamically significant heart disease, immunodeficiency, or neuromuscular disease * Children being discharged with home oxygen therapy

Design outcomes

Primary

MeasureTime frameDescription
AdoptionWithin 7 days of hospital dischargeProportion of participants who are prescribed PRN follow-up

Secondary

MeasureTime frameDescription
SustainmentWithin 7 days of hospital dischargeProportion of participants who attend a follow-up visit

Countries

Canada, United States

Contacts

CONTACTEric Coon, MD, MS
Eric.Coon@seattlechildrens.org206-884-1223
CONTACTChris Bonafide, MD, MSCE
bonafide@chop.edu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026